← All stocks

Kura Oncology, Inc.

KURA Net buying
CIK 0001422143 #2514 in the set updated 17 Sep 2026
Bought (120 mo)
$8.72M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$25.76M
$1.84M on a plan · $17.50M straight out of an exercise
Sold at will
$6.43M
56 of 101 sales
Net
−$17.04M
+$2.30M against sales at will

By person

14 insiders · 123 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
WILSON TROY EDWARD
President and CEO
$3.06M (5)
$18.91M (20) scheduled
−$15.84M
2,534,667
2.85%
$31.40M
−26.9%
EcoR1 Capital Fund Qualified, L.P. entity
10% owner
$5.08M (8)
$350.06K (1)
+$4.73M
4,408,097
4.96%
$54.62M
+8.6%
FORD KATHLEEN
Chief Operating Officer
$1.44M (15) scheduled
−$1.44M
153,560
0.1726%
$1.90M
+43.9%
Leoni Mollie
Chief Medical Officer
$1.23M (11) scheduled
−$1.23M
182,345
0.2050%
$2.26M
+288.2%
GRASSO MARC
CFO, CBO
$980.00K (4) scheduled
−$980.00K
21,900
0.0246%
$271.34K
+655.7%
Bair Teresa Brophy
Chief Legal Officer
$883.84K (13) scheduled
−$883.84K
195,444
0.2197%
$2.42M
+1,819%
Malley Thomas
Director
$575.00K (1)
+$575.00K
149,557
0.1681%
$1.85M
+67.0%
Powl Brian T.
Chief Commercial Officer
$410.35K (8)
−$410.35K
169,269
0.1903%
$2.10M
+24,866%
GUALBERTO ANTONIO
Head of Development & CMO
$379.90K (1) scheduled
−$379.90K
339,973
0.3822%
$4.21M
0.0%
DALE STEPHEN
Chief Medical Officer
$359.43K (5)
−$359.43K
38,817
0.0436%
$480.94K
Hasnain Faheem
Director
$291.22K (2) scheduled
−$291.22K
23,983
0.0270%
$297.15K
0.0%
Burrows Francis
Chief Scientific Officer
$260.07K (4) scheduled
−$260.07K
32,424
0.0364%
$401.73K
+31.7%
DOYLE THOMAS JAMES
SVP, Finance & Accounting
$253.49K (16)
−$253.49K
145,167
0.1632%
$1.80M
+793.0%
FLOWERS KIRSTEN
CCO & Chief Strategy Officer
$26.47K (1)
−$26.47K
20,605
0.0232%
$255.30K
+3,272%
Insider
Date
Role
Action
Shares
Price
Amount
WILSON TROY EDWARD
24 Aug 2026
President and CEO
Buy indirect
100,000
$12.39
$1.24M
WILSON TROY EDWARD
17 Aug 2026
President and CEO
Buy indirect
100,000
$11.12
$1.11M
WILSON TROY EDWARD
8 Sep 2025
President & CEO
Buy
50,000
$8.20
$410.15K
WILSON TROY EDWARD
13 Aug 2025
President and CEO
Buy
13,494
$6.64
$89.62K
WILSON TROY EDWARD
12 Aug 2025
President and CEO
Buy
36,506
$5.85
$213.58K
Malley Thomas
16 Jun 2023
Director
Buy indirect
50,000
$11.50
$575.00K
EcoR1 Capital Fund Qualified, L.P.
21 Dec 2018
10% owner
Buy
83,540
$13.16
$1.10M
EcoR1 Capital Fund Qualified, L.P.
19 Dec 2018
10% owner
Buy
51,879
$13.84
$718.01K
EcoR1 Capital Fund Qualified, L.P.
18 Dec 2018
10% owner
Buy
78,469
$13.82
$1.08M
EcoR1 Capital Fund Qualified, L.P.
13 Dec 2018
10% owner
Buy
25,217
$13.89
$350.26K
EcoR1 Capital Fund Qualified, L.P.
11 Dec 2018
10% owner
Buy
15,321
$13.91
$213.10K
EcoR1 Capital Fund Qualified, L.P.
6 Dec 2018
10% owner
Buy
17,079
$13.49
$230.40K
EcoR1 Capital Fund Qualified, L.P.
4 Dec 2018
10% owner
Buy
54,645
$13.08
$714.76K
EcoR1 Capital Fund Qualified, L.P.
3 Dec 2018
10% owner
Buy
48,182
$13.97
$673.10K

What was left out

Form 4 filings counted 214
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 30
Sales at will 56
Transactions with no price 0
Shares from compensation/vesting 6,232,237
Sales filed before the plan box existed 11
History held since 3 Jan 2017